Familial  ||| S:0 E:9 ||| FW
renal  ||| S:9 E:15 ||| FW
tubular  ||| S:15 E:23 ||| FW
acidosis  ||| S:23 E:32 ||| FW
The  ||| S:32 E:36 ||| DT
kidney  ||| S:36 E:43 ||| NN
maintains  ||| S:43 E:53 ||| VBZ
systemic  ||| S:53 E:62 ||| JJ
acid-base  ||| S:62 E:72 ||| JJ
homeostasis  ||| S:72 E:84 ||| NN
through  ||| S:84 E:92 ||| IN
proximal  ||| S:92 E:101 ||| JJ
tubular  ||| S:101 E:109 ||| JJ
reclamation  ||| S:109 E:121 ||| NN
of  ||| S:121 E:124 ||| IN
filtered  ||| S:124 E:133 ||| JJ
bicarbonate ||| S:133 E:144 ||| NN
,  ||| S:144 E:146 ||| ,
and  ||| S:146 E:150 ||| CC
excretion  ||| S:150 E:160 ||| NN
of  ||| S:160 E:163 ||| IN
the  ||| S:163 E:167 ||| DT
daily  ||| S:167 E:173 ||| JJ
mineral  ||| S:173 E:181 ||| NN
acid  ||| S:181 E:186 ||| NN
load  ||| S:186 E:191 ||| NN
by  ||| S:191 E:194 ||| IN
collecting  ||| S:194 E:205 ||| VBG
duct  ||| S:205 E:210 ||| JJ
type  ||| S:210 E:215 ||| NN
A  ||| S:215 E:217 ||| DT
intercalated  ||| S:217 E:230 ||| JJ
cells ||| S:230 E:235 ||| NNS
.  ||| S:235 E:237 ||| .
Impairment  ||| S:237 E:248 ||| NNP
of  ||| S:248 E:251 ||| IN
either  ||| S:251 E:258 ||| DT
process  ||| S:258 E:266 ||| NN
produces  ||| S:266 E:275 ||| VBZ
renal  ||| S:275 E:281 ||| JJ
tubular  ||| S:281 E:289 ||| JJ
acidosis  ||| S:289 E:298 ||| NNS
( ||| S:298 E:299 ||| -LRB-
RTA ||| S:299 E:302 ||| NNP
) ||| S:302 E:303 ||| -RRB-
.  ||| S:303 E:305 ||| .
This  ||| S:305 E:310 ||| DT
article  ||| S:310 E:318 ||| NN
will  ||| S:318 E:323 ||| MD
provide  ||| S:323 E:331 ||| VB
an  ||| S:331 E:334 ||| DT
overview  ||| S:334 E:343 ||| NN
of  ||| S:343 E:346 ||| IN
familial  ||| S:346 E:355 ||| JJ
forms  ||| S:355 E:361 ||| NNS
of  ||| S:361 E:364 ||| IN
proximal  ||| S:364 E:373 ||| NN
and  ||| S:373 E:377 ||| CC
distal  ||| S:377 E:384 ||| FW
renal  ||| S:384 E:390 ||| FW
tubular  ||| S:390 E:398 ||| FW
acidosis  ||| S:398 E:407 ||| FW
( ||| S:407 E:408 ||| -LRB-
pRTA  ||| S:408 E:413 ||| NNP
and  ||| S:413 E:417 ||| CC
dRTA ||| S:417 E:421 ||| NNP
) ||| S:421 E:422 ||| -RRB-
.  ||| S:422 E:424 ||| .
Recessive  ||| S:424 E:434 ||| JJ
pRTA  ||| S:434 E:439 ||| NN
with  ||| S:439 E:444 ||| IN
ocular  ||| S:444 E:451 ||| NN
and  ||| S:451 E:455 ||| CC
central  ||| S:455 E:463 ||| JJ
nervous  ||| S:463 E:471 ||| JJ
system  ||| S:471 E:478 ||| NN
abnormalities  ||| S:478 E:492 ||| NN
is  ||| S:492 E:495 ||| VBZ
caused  ||| S:495 E:502 ||| VBN
by  ||| S:502 E:505 ||| IN
loss-of-function  ||| S:505 E:522 ||| JJ
mutations  ||| S:522 E:532 ||| NNS
in  ||| S:532 E:535 ||| IN
basolateral  ||| S:535 E:547 ||| FW
membrane  ||| S:547 E:556 ||| FW
Na-HCO3-  ||| S:556 E:565 ||| FW
cotransporter  ||| S:565 E:579 ||| FW
NBCe1 ||| S:579 E:584 ||| FW
/  ||| S:584 E:586 ||| FW
SLC4A4 ||| S:586 E:592 ||| FW
.  ||| S:592 E:594 ||| .
Recessive  ||| S:594 E:604 ||| JJ
dRTA  ||| S:604 E:609 ||| NN
with  ||| S:609 E:614 ||| IN
deafness  ||| S:614 E:623 ||| NN
is  ||| S:623 E:626 ||| VBZ
caused  ||| S:626 E:633 ||| VBN
by  ||| S:633 E:636 ||| IN
loss-of-function  ||| S:636 E:653 ||| JJ
mutations  ||| S:653 E:663 ||| NNS
in  ||| S:663 E:666 ||| IN
either  ||| S:666 E:673 ||| RB
of  ||| S:673 E:676 ||| IN
2  ||| S:676 E:678 ||| CD
subunits  ||| S:678 E:687 ||| NN
of  ||| S:687 E:690 ||| IN
the  ||| S:690 E:694 ||| DT
vacuolar  ||| S:694 E:703 ||| JJ
H+-ATPase  ||| S:703 E:713 ||| NNP
( ||| S:713 E:714 ||| -LRB-
V-ATPase ||| S:714 E:722 ||| NNP
)  ||| S:722 E:724 ||| -RRB-
of  ||| S:724 E:727 ||| IN
intercalated  ||| S:727 E:740 ||| JJ
cells ||| S:740 E:745 ||| NNS
;  ||| S:745 E:747 ||| :
the  ||| S:747 E:751 ||| DT
B1  ||| S:751 E:754 ||| JJ
subunit  ||| S:754 E:762 ||| NN
of  ||| S:762 E:765 ||| IN
the  ||| S:765 E:769 ||| DT
V1  ||| S:769 E:772 ||| JJ
cytoplasmic  ||| S:772 E:784 ||| JJ
ATPase  ||| S:784 E:791 ||| JJ
complex ||| S:791 E:798 ||| NN
,  ||| S:798 E:800 ||| ,
and  ||| S:800 E:804 ||| CC
the  ||| S:804 E:808 ||| DT
a4  ||| S:808 E:811 ||| JJ
subunit  ||| S:811 E:819 ||| NN
of  ||| S:819 E:822 ||| IN
the  ||| S:822 E:826 ||| DT
V0  ||| S:826 E:829 ||| FW
transmembrane  ||| S:829 E:843 ||| FW
pore  ||| S:843 E:848 ||| FW
complex ||| S:848 E:855 ||| FW
.  ||| S:855 E:857 ||| .
Dominant  ||| S:857 E:866 ||| JJ
and  ||| S:866 E:870 ||| CC
recessive  ||| S:870 E:880 ||| JJ
forms  ||| S:880 E:886 ||| NNS
of  ||| S:886 E:889 ||| IN
dRTA  ||| S:889 E:894 ||| NNS
are  ||| S:894 E:898 ||| VBP
also  ||| S:898 E:903 ||| RB
caused  ||| S:903 E:910 ||| VBN
by  ||| S:910 E:913 ||| IN
loss-of-function  ||| S:913 E:930 ||| JJ
mutations  ||| S:930 E:940 ||| NNS
in  ||| S:940 E:943 ||| IN
the  ||| S:943 E:947 ||| DT
basolateral  ||| S:947 E:959 ||| FW
membrane  ||| S:959 E:968 ||| FW
AE1  ||| S:968 E:972 ||| FW
Cl- ||| S:972 E:975 ||| FW
/ ||| S:975 E:976 ||| FW
HCO3-  ||| S:976 E:982 ||| FW
exchanger  ||| S:982 E:992 ||| FW
of  ||| S:992 E:995 ||| IN
the  ||| S:995 E:999 ||| DT
type  ||| S:999 E:1004 ||| NN
A  ||| S:1004 E:1006 ||| DT
intercalated  ||| S:1006 E:1019 ||| JJ
cell ||| S:1019 E:1023 ||| NN
.  ||| S:1023 E:1025 ||| .
The  ||| S:1025 E:1029 ||| DT
dominant  ||| S:1029 E:1038 ||| JJ
AE1  ||| S:1038 E:1042 ||| CD
dRTA  ||| S:1042 E:1047 ||| JJ
mutations  ||| S:1047 E:1057 ||| NNS
are  ||| S:1057 E:1061 ||| VBP
accompanied  ||| S:1061 E:1073 ||| VBN
by  ||| S:1073 E:1076 ||| IN
mild  ||| S:1076 E:1081 ||| JJ
or  ||| S:1081 E:1084 ||| CC
asymptomatic  ||| S:1084 E:1097 ||| JJ
erythroid  ||| S:1097 E:1107 ||| JJ
changes ||| S:1107 E:1114 ||| NNS
,  ||| S:1114 E:1116 ||| ,
while  ||| S:1116 E:1122 ||| IN
the  ||| S:1122 E:1126 ||| DT
erythroid  ||| S:1126 E:1136 ||| FW
dyscrasias  ||| S:1136 E:1147 ||| FW
accompanying  ||| S:1147 E:1160 ||| FW
recessive  ||| S:1160 E:1170 ||| FW
AE1  ||| S:1170 E:1174 ||| FW
dRTA  ||| S:1174 E:1179 ||| FW
mutations  ||| S:1179 E:1189 ||| FW
can  ||| S:1189 E:1193 ||| MD
be  ||| S:1193 E:1196 ||| VB
mild  ||| S:1196 E:1201 ||| JJ
or  ||| S:1201 E:1204 ||| CC
severe ||| S:1204 E:1210 ||| JJ
.  ||| S:1210 E:1212 ||| .
Recessive  ||| S:1212 E:1222 ||| JJ
mixed  ||| S:1222 E:1228 ||| JJ
proximal-distal  ||| S:1228 E:1244 ||| JJ
RTA  ||| S:1244 E:1248 ||| NNP
is  ||| S:1248 E:1251 ||| VBZ
caused  ||| S:1251 E:1258 ||| VBN
by  ||| S:1258 E:1261 ||| IN
loss-of-function  ||| S:1261 E:1278 ||| JJ
mutations  ||| S:1278 E:1288 ||| NNS
of  ||| S:1288 E:1291 ||| IN
the  ||| S:1291 E:1295 ||| DT
cytoplasmic  ||| S:1295 E:1307 ||| FW
carbonic  ||| S:1307 E:1316 ||| FW
anhydrase  ||| S:1316 E:1326 ||| FW
II ||| S:1326 E:1328 ||| NNP
.  ||| S:1328 E:1330 ||| .
Hyperkalemic  ||| S:1330 E:1343 ||| NNP
RTA  ||| S:1343 E:1347 ||| NNP
accompanied  ||| S:1347 E:1359 ||| VBD
by  ||| S:1359 E:1362 ||| IN
hypertension  ||| S:1362 E:1375 ||| NN
( ||| S:1375 E:1376 ||| -LRB-
pseudohypoaldosteronism  ||| S:1376 E:1400 ||| JJ
type  ||| S:1400 E:1405 ||| NN
2  ||| S:1405 E:1407 ||| CD
[ ||| S:1407 E:1408 ||| -LRB-
PHA2 ||| S:1408 E:1412 ||| NNP
] ||| S:1412 E:1413 ||| -RRB-
)  ||| S:1413 E:1415 ||| -RRB-
is  ||| S:1415 E:1418 ||| VBZ
caused  ||| S:1418 E:1425 ||| VBN
by  ||| S:1425 E:1428 ||| IN
dominant  ||| S:1428 E:1437 ||| JJ
gain-of-function  ||| S:1437 E:1454 ||| JJ
mutations  ||| S:1454 E:1464 ||| NNS
in  ||| S:1464 E:1467 ||| IN
the  ||| S:1467 E:1471 ||| DT
kinases  ||| S:1471 E:1479 ||| JJ
WNK1  ||| S:1479 E:1484 ||| NN
and  ||| S:1484 E:1488 ||| CC
WNK4 ||| S:1488 E:1492 ||| NNP
.  ||| S:1492 E:1494 ||| .
Hyperkalemic  ||| S:1494 E:1507 ||| NNP
RTA  ||| S:1507 E:1511 ||| NNP
accompanied  ||| S:1511 E:1523 ||| VBD
by  ||| S:1523 E:1526 ||| IN
volume  ||| S:1526 E:1533 ||| NN
depletion  ||| S:1533 E:1543 ||| NN
is  ||| S:1543 E:1546 ||| VBZ
caused  ||| S:1546 E:1553 ||| VBN
by  ||| S:1553 E:1556 ||| IN
loss-of-function  ||| S:1556 E:1573 ||| JJ
mutations  ||| S:1573 E:1583 ||| NNS
in  ||| S:1583 E:1586 ||| IN
genes  ||| S:1586 E:1592 ||| NNS
encoding  ||| S:1592 E:1601 ||| VBP
the  ||| S:1601 E:1605 ||| DT
mineralocorticoid  ||| S:1605 E:1623 ||| JJ
receptor  ||| S:1623 E:1632 ||| NN
or  ||| S:1632 E:1635 ||| CC
the  ||| S:1635 E:1639 ||| DT
epithelial  ||| S:1639 E:1650 ||| JJ
Na+  ||| S:1650 E:1654 ||| CD
channel  ||| S:1654 E:1662 ||| NN
( ||| S:1662 E:1663 ||| -LRB-
ENaC ||| S:1663 E:1667 ||| NNP
)  ||| S:1667 E:1669 ||| -RRB-
subunits ||| S:1669 E:1677 ||| NN
.  ||| S:1677 E:1679 ||| .
Additional  ||| S:1679 E:1690 ||| JJ
RTA  ||| S:1690 E:1694 ||| NN
genes  ||| S:1694 E:1700 ||| NNS
identified  ||| S:1700 E:1711 ||| VBN
in  ||| S:1711 E:1714 ||| IN
knockout  ||| S:1714 E:1723 ||| JJ
mice  ||| S:1723 E:1728 ||| NNS
may  ||| S:1728 E:1732 ||| MD
lead  ||| S:1732 E:1737 ||| VB
to  ||| S:1737 E:1740 ||| TO
identification  ||| S:1740 E:1755 ||| VB
of  ||| S:1755 E:1758 ||| IN
additional  ||| S:1758 E:1769 ||| JJ
human  ||| S:1769 E:1775 ||| JJ
RTA  ||| S:1775 E:1779 ||| NN
genes ||| S:1779 E:1784 ||| NNS
.  ||| S:1784 E:1786 ||| .
